| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Jenkins John Kenneth serves as a Director at CRBP. Across recent SEC filings that breaks down to 1 buy and 2 sells. Those positions are worth an estimated $30K at current prices.
The biggest single holding is CRBP (~$30K) as Director. The recent filings there lean toward selling, a net 6,583 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Director | Sell10b5-1 | 4,800 | $7.91 | $37,985.76 | -55.6% | +37.6% | - | |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Director | Sell10b5-1 | 2,783 | $7.35 | $20,465.35 | -98.8% | +33.4% | - | |
| Mar 15, 2019 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Director | Buy | 1,000 | $6.98 | $6,977.90 | New | - | - |